Glucose Tolerance Test Market Size, Share, Growth Analysis, By Product(Smart Sensor, Blood Glucose Testing Kit, Meters, Test Slips and Other), By Disease Indication(Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance), By End User(Hospitals, Home, Diagnostic Clinic, and Others), By Region - Industry Forecast 2024-2031

Global Glucose Tolerance Test Market size was valued at USD 25603 million in 2022, USD 27110 million in 2023 and is projected to grow USD 41750 million by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The market is expanding due to rising diabetes rates, technical developments, and rising public awareness of the benefits of point-of-care glucose testing. With the growing popularity of needle-free blood glucose monitoring devices, many major players are providing patients with painless diabetes care. Recently, the Clinical & Laboratories Standard Institute, an international organization, standardized the accuracy guidelines for point-of-care glucose testing. Using the POCT device is common in the critical care unit. POC testing has become more necessary in recent years.

Also, it is anticipated that the need for glucose diagnostics would rise due to the unmet medical needs for diabetes diagnosis and management and the rise in patient awareness. The International Diabetes Federation estimates that 537 million people worldwide have diabetes in 2021; by 2030, that figure is expected to rise to 643 million, and by 2045, it is expected to reach 783 million. The need for Short Turn-Around Testing (STAT) has surged because of the healthcare industry's emphasis on improved acute care, shorter hospital stays, and the growth of outlying surgical centers. Solutions for managing glucose tests make it simple for patients and medical professionals to gather, share, and keep track of specimens to comply with legal obligations.